Opportunity overview
GSTT will lead the development of a national clinical metagenomics pilot service by deploying NHS developed laboratory, bioinformatic and clinical protocols along with Oxford Nanopore developed sequencing technology to a network of 30 NHS sites across the UK for the dual benefit of patient care and bio-surveillance.
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Oxford Nanopore Technologies PLC
- Contract value
- £7m
- Awarded
- Not supplied
- Contract signed
- 21 Nov 2025
- Including VAT
- £7m
- Award ID
- 2
- Status
- active
- Identifier
- GB-PPON PNQY-3648-RQHN
- Location
- Oxford, UKJ14, OX4 4DQ, United Kingdom
Classification
No classification was supplied.
Lots
- Lot 1Value not stated
Documents and notices
- Contract details notice on Find a TenderOpen source ↗
- GSTT will lead the development of a national clinical metagenomics pilot service by deploying NHS developed laboratory, bioinformatic and clinical protocols along with Oxford Nanopore developed sequencing technology to a network of 30 NHS sites across the UK for the dual benefit of patient care and bio-surveillance.Open source ↗